Clinical Trials Directory

Trials / Terminated

TerminatedNCT02237677

CB1 Receptor PET Imaging Reveals Gender Differences in PTSD

Cannabinoid-1 (CB1) Receptor Positron Emission Tomography (PET) Imaging Reveals Gender Differences in Posttraumatic Stress Disorder (PTSD)

Status
Terminated
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The objective of the proposed translational study is to test a model, based upon basic science studies, exploring multisystem impairments in PTSD including endocannabinoid (eCB) and glucocorticoids in the modulation of fear memories by examining the cannabinoid type 1 (CB1) receptor in a PTSD fear circuit as well as glucocorticoid function. The investigators propose that impaired eCB signaling in PTSD resulting in the maladaptive neurobehavioral response to the stressor is associated with an upregulation of the CB1 receptors and insufficient glucocorticoid signaling.

Detailed description

The eCB - anandamide and 2-arachidonoylglycerol (2-AG) - and their attending cannabinoid (CB) receptors which are found in high densities in a fear circuitry involving the amygdala, hippocampus, the anterior cingulate cortex and prefrontal cortex serve important functions in the regulation of stress-coping behaviors. Besides eCB regulation there is strong evidence from ongoing research of the investigators group and others suggesting an important role for glucocorticoid signaling as an endpoint of the biochemical sequelae initiated by stressful or aversive stimuli. One of the long-term research goals of our lab is to understand such functions and determine their relevance to the pathogenesis of PTSD and to provide a more integrative view on neurobiological mechanisms that are involved in the regulation of the neuroadaptive response to stress. The objective of the proposed translational study is to test a model, based upon basic science studies, exploring multisystem impairments in PTSD including eCB and glucocorticoids in the modulation of fear memories by examining the CB1 receptor in a PTSD fear circuit as well as glucocorticoid function. The investigators propose that impaired eCB signaling in PTSD resulting in the maladaptive neurobehavioral response to the stressor is associated with an upregulation of the CB1 receptors and insufficient glucocorticoid signaling.

Conditions

Interventions

TypeNameDescription
OTHERPositron emission tomography (PET) imagingPositron emission tomography (PET) imaging

Timeline

Start date
2012-06-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2014-09-11
Last updated
2016-08-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02237677. Inclusion in this directory is not an endorsement.

CB1 Receptor PET Imaging Reveals Gender Differences in PTSD (NCT02237677) · Clinical Trials Directory